A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trials
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trials
Authors
Keywords
Metaanalysis, Prostate cancer, Systematic reviews, Metastasis, Radiation therapy, Prostate gland, Medical risk factors, Cancer treatment
Journal
PLOS MEDICINE
Volume 18, Issue 5, Pages e1003629
Publisher
Public Library of Science (PLoS)
Online
2021-05-07
DOI
10.1371/journal.pmed.1003629
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of aggregate and individual participant data approaches to meta-analysis of randomised trials: An observational study
- (2020) Jayne F. Tierney et al. PLOS MEDICINE
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data
- (2020) Claire L Vale et al. LANCET
- Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial
- (2020) Christopher C Parker et al. LANCET
- Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial
- (2020) Andrew Kneebone et al. LANCET ONCOLOGY
- Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial
- (2020) Paul Sargos et al. LANCET ONCOLOGY
- Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19
- (2020) Huseyin Naci et al. BMJ-British Medical Journal
- Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis
- (2019) Sarah Burdett et al. EUROPEAN UROLOGY
- A guide to prospective meta-analysis
- (2019) Anna Lene Seidler et al. BMJ-British Medical Journal
- Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis
- (2017) Larysa H.M. Rydzewska et al. EUROPEAN JOURNAL OF CANCER
- Living systematic review: 1. Introduction—the why, what, when, and how
- (2017) Julian H. Elliott et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
- (2017) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
- (2017) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?
- (2017) David J Fisher et al. BMJ-British Medical Journal
- Impact of searching clinical trial registries in systematic reviews of pharmaceutical treatments: methodological systematic review and reanalysis of meta-analyses
- (2017) Marie Baudard et al. BMJ-British Medical Journal
- Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?
- (2017) David J Fisher et al. BMJ-British Medical Journal
- Impact of searching clinical trial registries in systematic reviews of pharmaceutical treatments: methodological systematic review and reanalysis of meta-analyses
- (2017) Marie Baudard et al. BMJ-British Medical Journal
- Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer
- (2016) Perrine Créquit et al. BMC Medicine
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
- (2016) Claire L Vale et al. LANCET ONCOLOGY
- Continuously updated network meta-analysis and statistical monitoring for timely decision-making
- (2016) Adriani Nikolakopoulou et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review
- (2016) Georgina Imberger et al. BMJ Open
- Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study
- (2016) Matthew J. Page et al. PLOS MEDICINE
- Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use
- (2015) Jayne F. Tierney et al. PLOS MEDICINE
- Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews
- (2013) C. L. Vale et al. BMJ-British Medical Journal
- Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis
- (2007) Jørn Wetterslev et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now